What is Intracranial Hypertension

Intracranial Hypertension, often referred to as Pseudotumor Cerebri (PTC), is a condition characterized by high pressure of the cerebrospinal fluid surrounding the brain, mimicking the symptoms of a brain tumor despite no tumor being present. This elevated pressure can cause significant neurological and visual complications, requiring careful medical management to prevent permanent damage.

What exactly is Intracranial Hypertension?

Intracranial Hypertension occurs when the pressure of the fluid that cushions the brain and spinal cord becomes too high. In a healthy state, this fluid is constantly produced and absorbed; however, in patients with Intracranial Hypertension, this balance is disrupted. Because the skull is a rigid container, this excess fluid exerts pressure on the brain and the optic nerves. Over 2,580 people living with Intracranial Hypertension have joined the DiseaseMaps.org community to share their experiences, highlighting the significant impact this condition has on daily life.

Which body systems are affected by Intracranial Hypertension?

While the root cause is neurological, the effects of Intracranial Hypertension are systemic. The primary systems involved include:

• Nervous System: The brain and optic nerves are directly affected by the pressure, leading to symptoms like debilitating headaches, dizziness, and vision changes.


• Digestive System: Many patients experience significant nausea and vomiting, often as a secondary reaction to the intracranial pressure and the intense pain associated with the condition.


• Ocular System: The optic nerves are particularly vulnerable to pressure, which can lead to papilledema (swelling of the optic disc), double vision, and potential permanent vision loss if left untreated.

How common is Intracranial Hypertension and who is at risk?

Intracranial Hypertension is classified as a rare disease. While exact global prevalence is difficult to determine, it is most frequently diagnosed in women of childbearing age, particularly those who are overweight, though it can affect individuals of any gender, age, or weight. The condition is often split into two categories: primary (idiopathic) Intracranial Hypertension, where the cause is unknown, and secondary, which can be linked to medications, hormonal changes, or other underlying health issues.

What is the underlying mechanism of the condition?

The pathophysiology of Intracranial Hypertension involves a failure in the drainage or absorption of cerebrospinal fluid. When the fluid cannot drain at the same rate it is produced, it accumulates. This differentiates it from conditions like hydrocephalus, where fluid builds up inside the brain's ventricles. Instead, Intracranial Hypertension involves high pressure in the subarachnoid space. Key differentiating factors include the presence of pulsatile tinnitus—a rhythmic ringing in the ears synchronized with the heartbeat—and the absence of mass lesions on neuroimaging, which distinguishes it from actual brain tumors.

Next steps

• Consult a neurologist or neuro-ophthalmologist to discuss your symptoms and undergo a baseline eye exam.


• Request an MRI or MRV (Magnetic Resonance Venography) to rule out other causes of high pressure.


• Join the DiseaseMaps community to connect with over 2,500 peers who understand the daily challenges of living with this condition.


• Discuss potential management strategies, such as diuretics or, in severe cases, surgical interventions like shunts or venous sinus stenting.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases (GARD) Information Center.


• Orphanet: Information on Idiopathic Intracranial Hypertension.


• The International Intracranial Hypertension Research Foundation (IIHRF).


• PubMed/NCBI: Clinical reviews on the management of Pseudotumor Cerebri.